Background parenchymal enhancement on breast MRI refers to the normal contrast enhancement of fibroglandular tissue.

Aug 25, 2022 · We examined the relationship between BPE and the amount of fibroglandular tissue on MRI (MRI-FGT) and breast cancer risk factors. This was a cross-sectional study of 415 women …

May 29, 2025 · The degree of background parenchymal enhancement (BPE) has an impact on the diagnostic performance of breast MRI, with minimal or mild BPE being associated with higher …

Current clinical assessment qualitatively describes background parenchymal enhancement (BPE) as minimal, mild, moderate, or marked based on the visually perceived volume and intensity of …

Dec 7, 2020 · Background parenchymal enhancement (BPE) on breast magnetic resonance imaging (MRI) may be associated with breast cancer risk, but previous studies of the association are …

BPE is typically minimal or mild, characterized by a bilateral, symmetrical, and diffuse distribution, with slow initial enhancement and persistent and delayed kinetic curves.

Dec 1, 2018 · Background parenchymal enhancement (BPE) on breast magnetic resonance imaging (MRI) is a dynamic process, which varies among women and within the same woman over time due …

Sep 30, 2021 · The level of background parenchymal enhancement (BPE) reflects the features of enhanced FGT. Some studies have demonstrated that the breast tissue showing enhancement upon …

Jun 2, 2025 · Dynamic contrast-enhanced (DCE)-MRI provides information about the morphology and function of a lesion with high sensitivity but moderate specificity (72%) which leads to subsequent …

Normal fibroglandular tissue within the breast may enhance, resulting in BPE. BPE is characterized as minimal, mild, moderate, or marked. Although fibroglandular tissue is correlated with mam-mographic …